Home > Insider Trading > Filing (0001209191-14-059642)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Tokai Pharmaceuticals Inc	TKAI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553255	Apple Tree Partners Ii - Annex, L.p.	47 Hulfish Street Suite 441 Princeton NJ 08542		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-22	3,330,938	$0.00	3,330,938	No	4	C	Direct
Common Stock	Acquisiton	2014-09-22	237,500	$15.00	3,568,438	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D-3 Preferred Stock	Disposition	2014-09-22	10,675,613	$0.00	1,019,638	$0.00
Common Stock	Series E Preferred Stock	Disposition	2014-09-22	24,199,308	$0.00	2,311,300	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

The Series D-3 and Series E Preferred Stock converted into Common Stock on a 10.47-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D-3 and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Apple Tree Partners II - Annex, L.P. acquired 237,500 shares of Common Stock in the Issuer's initial public offering.